Studying Ways to Improve Detection of Pancreatic Cancer and Disorders
NCT00830557 · RecruitingThis trial is focused on gathering medical information and tissue samples from patients with pancreatic cancer and other pancreatic disorders. The goal is to help doctors find better ways to screen and detect these conditions in the future. By collecting blood, saliva, and leftover tissue samples, researchers aim to discover new ways to spot risks and develop treatments for pancreatic diseases.
Locations and contact
This trial is running at 3 locations in the United States. All of them are currently recruiting.
United States3 locations · 3 recruiting
- Mayo Clinic Hospital in ArizonaPhoenix, ArizonaRecruiting
- Mayo Clinic in FloridaJacksonville, FloridaRecruiting
- Mayo Clinic in RochesterRochester, MinnesotaRecruiting
Who can join
Adults aged 18 and older can join, including both men and women. You can participate if you have known or suspected pancreatic disease, such as pancreatic cancer or pancreatitis. If a participant has passed away, their next of kin may also be eligible. However, those under 18, unable to provide consent, or prison inmates cannot join. The trial team will confirm eligibility.
What happens during the trial
Participants will provide blood and saliva samples and allow the use of leftover tissue samples. They will complete questionnaires about their health and family history. Participants will also have their medical records reviewed. This is an observational study, meaning there are no treatments given, only data collection.
The trial team
The trial is led by the Mayo Clinic, with Dr. Shounak Majumder as the principal investigator. The National Cancer Institute is a partner in this study.
Important dates
The trial started on October 1, 2000, and is currently recruiting new participants. It is expected to finish by August 30, 2027.
Additional information
This trial is identified as NCT00830557. It is an observational study, which means it is gathering information rather than testing a treatment. Around 20,000 participants are expected to join this trial.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →